[Renal protection with antagonists of the angiotensin II receptors].
Aranda
P
P
Unidad de HTA y Valoración de Riesgo Vascular, Hospital Regional Carlos Haya, Málaga. parand@farmanet.com
Aranda F
J
J
D000804:Angiotensin II / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007668:Kidney / Q000098:blood supply / Q000378:metabolism*; D011945:Receptors, Angiotensin / Q000378:metabolism*; D012079:Renal Circulation / Q000187:drug effects; D012083:Renin / Q000378:metabolism; D014664:Vasodilation / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D012083:Renin